ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,761Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 1185

$1.64M Total Retail Price of All Prescriptions

Rank: 6 out of 1185

506 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 506 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 506 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 22,770 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
OMEPRAZOLE 824 721 1 6
AMLODIPINE BESYLATE 800 731 2 1
FUROSEMIDE 762 644 3 8
METOPROLOL TARTRATE 722 663 4 10
LISINOPRIL 671 637 5 4
LEVOTHYROXINE SODIUM 645 588 6 3
PRAVASTATIN SODIUM 624 524 7 7
NAMENDA 575 575 8 43
EXELON 461 461 9 120
CARVEDILOL 434 392 10 24
SIMVASTATIN 418 388 11 5
HYDROCHLOROTHIAZIDE 406 380 12 12
HYDROCODONE-ACETAMINOPHEN 369 239 S3 13 2
GABAPENTIN 325 255 14 13
KLOR-CON M20 304 251 15 59
METFORMIN HCL 302 258 16 9
POTASSIUM CHLORIDE 289 263 17 18
IPRATROPIUM-ALBUTEROL 287 287 18 164
LANTUS 282 271 19 66
ZOLPIDEM TARTRATE 282 230 19 15
DIVALPROEX SODIUM 279 279 21 96
PREDNISONE 274 236 22 33
DONEPEZIL HCL 253 253 23 32
NOVOLOG 248 237 24 127
MIRTAZAPINE 233 233 25 57
CLOPIDOGREL 232 217 26 31
WARFARIN SODIUM 214 189 27 21
ESCITALOPRAM OXALATE 209 198 28 79
NEXIUM 201 168 29 19
TRAMADOL HCL 199 131 30 16
RANITIDINE HCL 197 185 31 17
BENAZEPRIL HCL 196 161 32 41
POLYETHYLENE GLYCOL 3350 183 181 33 60
FLUTICASONE PROPIONATE 181 149 34 29
DIOVAN 180 178 35 37
SPIRONOLACTONE 177 142 36 75
PLAVIX 176 156 37 45
CITALOPRAM HBR 174 155 38 22
ATORVASTATIN CALCIUM 173 149 39 11
FENTANYL 172 159 S2 40 107
DIGOXIN 171 159 41 67
TAMSULOSIN HCL 169 149 42 34
PANTOPRAZOLE SODIUM 168 128 43 58
QUETIAPINE FUMARATE 164 164 44 93
LOSARTAN POTASSIUM 149 149 45 26
CRESTOR 145 126 46 23
CYMBALTA 138 124 47 44
MEGESTROL ACETATE 136 136 R 48 170
METOPROLOL SUCCINATE 126 99 49 20
ISOSORBIDE MONONITRATE ER 122 108 50 48
TRIAMCINOLONE ACETONIDE 122 97 50 130
NITROGLYCERIN PATCH 120 120 52 202
BUMETANIDE 120 120 52 190
ALENDRONATE SODIUM 119 102 54 40
GLIMEPIRIDE 117 100 55 49
TRAZODONE HCL 117 106 55 38
LEVOFLOXACIN 115 107 57 109
CLONIDINE HCL 114 78 58 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 113 101 59 14
SYNTHROID 110 97 60 61
E.E.S. 200 108 108 10 61 328
HYDRALAZINE HCL 108 108 61 112
ATENOLOL-CHLORTHALIDONE 107 74 63 122
NITROFURANTOIN MONO-MACRO 106 103 64 219
PROMETHAZINE HCL 103 84 R 65 76
RISPERIDONE 100 100 66 72
OXYCODONE-ACETAMINOPHEN 100 81 S2 66 94
SERTRALINE HCL 98 93 68 25
CARBIDOPA-LEVODOPA 97 86 69 142
CIPROFLOXACIN HCL 93 83 70 62
DOXAZOSIN MESYLATE 92 82 71 84
NYSTATIN 92 83 71 197
ADVAIR DISKUS 91 60 73 54
AMLODIPINE BESYLATE-BENAZEPRIL 90 70 74 42
SULFAMETHOXAZOLE-TRIMETHOPRIM 89 87 75 91
VALPROIC ACID 89 72 75 213
METOCLOPRAMIDE HCL 87 71 77 134
DILTIAZEM HCL 86 76 78 228
ATENOLOL 86 75 78 28
ALLOPURINOL 85 77 80 30
OLANZAPINE 84 84 81 156
ROPINIROLE HCL 82 60 82 108
LEVETIRACETAM 79 64 83 131
BUDESONIDE 77 77 84 290
OXYCODONE HCL-ACETAMINOPHEN 77 60 S2 84 82
FLUOXETINE HCL 75 58 86 52
COLCRYS 75 73 86 110
FLUCONAZOLE 72 66 88 147
OXYBUTYNIN CHLORIDE ER 71 53 89 173
LEXAPRO 71 68 89 227
NIFEDIPINE ER 70 68 91 97
CYCLOBENZAPRINE HCL 68 53 R 92 53
GLIPIZIDE 68 68 92 56
NYSTOP 67 67 94 253
VERAPAMIL ER 67 57 94 98
SEROQUEL 66 66 96 159
CEFTRIAXONE 66 66 96 295
LIPITOR 65 49 98 89
AMOXICILLIN 65 52 98 99
CEPHALEXIN 59 58 100 103
RANEXA 58 39 101 328
ARANESP 58 58 101 376
AZITHROMYCIN 58 49 101 39
MECLIZINE HCL 58 46 101 115
TRIMETHOPRIM 56 56 105 320
HYDROCORTISONE 56 56 105 301
MELOXICAM 55 43 107 27
NAPROXEN 55 53 107 92
VENLAFAXINE HCL ER 54 54 109 105
KLOR-CON M10 54 54 109 141
DEXILANT 54 30 109 189
SPIRIVA 53 51 112 64
DIOVAN HCT 52 41 113 46
DILTIAZEM ER 52 51 113 153
SUCRALFATE 51 18 115 171
PHENYTOIN 51 51 115 232
LYRICA 50 36 117 74
GLYCOPYRROLATE 50 43 117 401
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.